Patent Daily RSS
December 2019 M T W T F S S « Nov 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Twitter Guna
- Happy #gobackmodi day 10 months ago
- RT @nikhilkarani1: Aurobindo acquires oral solid & derm Biz of Sandoz - Acqd Biz has sales worth $1.2bn & Aurobindo wud pay $900mn in cash… 1 year ago
- RT @ainvvy: 0. On Independence day, I look briefly at how some of the current states came into being. Some of them I had not even heard be… 1 year ago
- RT @digvijaya_28: Political turmoil in TN and Governor playing truant. Is he fulfilling his duties ? No. He is doing politics under directi… 2 years ago
- RT @VikasDandekarET: #Cipla bets on speciality #pharma business in US; aims for commercial launches by 2020 economictimes.indiatimes.com/industry/healt… 3 years ago
- RT @scarthik: @itisprashanth வாழ்வில் நமதுதேவை குறித்த தெளிவான தேர்வும், அதைநோக்கிய நேர்மையான தேடலும்இருந்துவிட்டால், வெற்றி கூடிவரும். அமை… 3 years ago
Tag Archives: Synagis
Novartis sues Medimmune, Biogen and Alexion
[Bloomberg] Novartis sues Medimmune (subsidiary of astrazeneca), Biogen and Alexion pharmaceuticals on US patent 5688688. The target products are AstraZeneca’s Synagisrespiratory treatment; Biogen’s Tysabri for multiple sclerosis; and Alexion’s Soliris, used to treat a life-threatening form of anemia View complaint on prior smart Filed on … Continue reading
Posted in Patent case
Tagged Alexion, Astrazeneca, Biogen, Medimmune, Novartis, Soliris, Synagis, Tysabri
Leave a comment